Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a heavily desmoplastic and immunologically quiescent tumor. This complex immunosuppressive tumor microenvironment (TME) and marked desmoplasia act to insulate the tumor against an effective cytotoxic immune response. Thus far, no single immunotherapy strategy has proved to be effective, warranting investigation of combination approaches to improve efficacy. The potential of fibroblast activation protein (FAP) targeted radionuclide therapy (TRT) using 177 Lu-FAP-2286 to induce immunogenic cell death and reshape the TME was assessed in vitro and in vivo. Then, 177 Lu-FAP-2286 and CAR-T therapy were sequentially used in PDAC model mice to evaluate their combinatory efficacy. 177 Lu-FAP-2286 could induce the immunogenic death of FAP + cancer-associated fibroblasts (CAFs) and nearby cancerous cells, shifting the PDAC microenvironment toward a more permissive, pro-inflammatory state, thereby greatly enhancing CAR-Ts tumor accumulation and in vivo persistence. The sequential use of low-dose TRT and a single dose of CAR-Ts achieved a parallel outcome as two infusions of CAR-Ts therapy. The sequential use of TRT and CAR-T therapy may partially alleviate the burden of CAR-T administration and represents a promising strategy worthy of further translational evaluation in immunotherapy‑refractory PDAC.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Immunotherapy
Published
2026-11-19
DOI
https://doi.org/10.1007/s00262-026-04642-2
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma

Ping Lei, Kui Xu, Jiali Li, Jing Cao et al.
Cancer Immunology Immunotherapy
Peptidase Inhibition and Analysis
article

Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma

Ping Lei, Kui Xu, Jiali Li, Jing Cao, Yirui Zhang, Yibing Lv, Junyi Xiao, Wenhao Niu, Binchen Wang, Tingting Wang, Mingxuan Li, Yong He
article en

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a heavily desmoplastic and immunologically quiescent tumor. This complex immunosuppressive tumor microenvironment (TME) and marked desmoplasia act to insulate the tumor against an effective cytotoxic immune response. Thus far, no single immunotherapy strategy has proved to be effective, warranting investigation of combination approaches to improve efficacy. The potential of fibroblast activation protein (FAP) targeted radionuclide therapy (TRT) using 177 Lu-FAP-2286 to induce immunogenic cell death and reshape the TME was assessed in vitro and in vivo. Then, 177 Lu-FAP-2286 and CAR-T therapy were sequentially used in PDAC model mice to evaluate their combinatory efficacy. 177 Lu-FAP-2286 could induce the immunogenic death of FAP + cancer-associated fibroblasts (CAFs) and nearby cancerous cells, shifting the PDAC microenvironment toward a more permissive, pro-inflammatory state, thereby greatly enhancing CAR-Ts tumor accumulation and in vivo persistence. The sequential use of low-dose TRT and a single dose of CAR-Ts achieved a parallel outcome as two infusions of CAR-Ts therapy. The sequential use of TRT and CAR-T therapy may partially alleviate the burden of CAR-T administration and represents a promising strategy worthy of further translational evaluation in immunotherapy‑refractory PDAC.

Cancer Immunology Immunotherapy
Zhejiang Chinese Medical University (CN), Shanxi Medical University (CN), Zhejiang Provincial Hospital of TCM (CN), Zhongnan Hospital of Wuhan University (CN), Henan Provincial People's Hospital (CN), Shanxi Provincial People’s Hospital (CN), Huazhong University of Science and Technology (CN)
Peptidase Inhibition and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon